Related references
Note: Only part of the references are listed.Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2
Idowu A. Kehinde et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2022)
Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19
Enrique J. deAndres-Galiana et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19
SeyedehMozhdeh Mirmohammadi et al.
INFECTION GENETICS AND EVOLUTION (2022)
Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open- label, single-center phase 3 randomized clinical trial
Jiro Terada et al.
ECLINICALMEDICINE (2022)
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
Mubarak A. Alamri et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19
Chandrabose Selvaraj et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs
Zhiwei Feng et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
Manikandan Alagumuthu et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2021)
Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
Ahmed M. Darwesh et al.
PHARMACOLOGY & THERAPEUTICS (2021)
A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing
K. Deepthi et al.
APPLIED SOFT COMPUTING (2021)
Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities
Nimisha Ghosh et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment
Alisa Pavel et al.
BRIEFINGS IN BIOINFORMATICS (2021)
HVIDB: a comprehensive database for human-virus protein-protein interactions
Xiaodi Yang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Leveraging publicly available coronavirus data to identify new therapeutic targets for COVID-19
Stacy L. Sell et al.
PLOS ONE (2021)
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy
Emanuel Wyler et al.
ISCIENCE (2021)
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Keivan Ranjbar et al.
BMC INFECTIOUS DISEASES (2021)
Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2
Thirumal D. Kumar et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Automatic detection of coronavirus disease (COVID-19) in X-ray and CT images: A machine learning based approach
Sara Hosseinzadeh Kassani et al.
BIOCYBERNETICS AND BIOMEDICAL ENGINEERING (2021)
Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization
Gita A. Pathak et al.
NATURE COMMUNICATIONS (2021)
A machine learning platform to estimate anti-SARS-CoV-2 activities
Govinda B. KC et al.
NATURE MACHINE INTELLIGENCE (2021)
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Yiyue Ge et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches
Mahmoud A. El Hassab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
Jianchang Hu et al.
HUMAN GENOMICS (2021)
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis
Jingjiao Li et al.
MED (2021)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Nutritional status of patients with COVID-19
Jae Hyoung Im et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
Edison Ong et al.
FRONTIERS IN IMMUNOLOGY (2020)
Current Status of COVID-19 Therapies and Drug Repositioning Applications
Ozlem Altay et al.
ISCIENCE (2020)
Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies
Rohit Batra et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins
Lopamudra Dey et al.
BIOMEDICAL JOURNAL (2020)
DeepPurpose: a deep learning library for drug-target interaction prediction
Kexin Huang et al.
BIOINFORMATICS (2020)
Mapping the landscape of Artificial Intelligence applications against COVID-19
Joseph Bullock et al.
JOURNAL OF ARTIFICIAL INTELLIGENCE RESEARCH (2020)
Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis
Mahesha Nand et al.
SCIENTIFIC REPORTS (2020)
Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19
Basavaraj Vastrad et al.
GENE REPORTS (2020)
COVID-19 Outbreak Prediction with Machine Learning
Sina F. Ardabili et al.
ALGORITHMS (2020)
Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space
Joel Kowalewski et al.
HELIYON (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
A two-step framework for inferring direct protein-protein interaction network from AP-MS data
Bo Tian et al.
BMC SYSTEMS BIOLOGY (2017)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
PaDEL-Descriptor: An Open Source Software to Calculate Molecular Descriptors and Fingerprints
Chun Wei Yap
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Precision and recall estimates for two-hybrid screens
Hailiang Huang et al.
BIOINFORMATICS (2009)
Analysis of protein complexes using mass spectrometry
Anne-Claude Gingras et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells
Tilmann Buerckstuemmer et al.
NATURE METHODS (2006)
PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence
Z. R. Li et al.
NUCLEIC ACIDS RESEARCH (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Molecular drug targets and structure based drug design: A holistic approach
Shailza Singh et al.
BIOINFORMATION (2006)
New methodologies for measuring protein interactions in vivo and in vitro
J Piehler
CURRENT OPINION IN STRUCTURAL BIOLOGY (2005)
Docking and scoring in virtual screening for drug discovery: Methods and applications
DB Kitchen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry
Y Ho et al.
NATURE (2002)
Systematic genetic analysis with ordered arrays of yeast deletion mutants
AHY Tong et al.
SCIENCE (2001)
Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae
H Ge et al.
NATURE GENETICS (2001)
A comprehensive two-hybrid analysis to explore the yeast protein interactome
T Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
